Dey Sangeeta, Das Mitun, Balla Vamsi Krishna
Bioceramics and Coating Division, CSIR-Central Glass & Ceramic Research Institute, 196, Raja S. C. Mullick Road, Kolkata 700032, India.
Bioceramics and Coating Division, CSIR-Central Glass & Ceramic Research Institute, 196, Raja S. C. Mullick Road, Kolkata 700032, India.
Mater Sci Eng C Mater Biol Appl. 2014 Jun 1;39:336-9. doi: 10.1016/j.msec.2014.03.022. Epub 2014 Mar 15.
The aim of the present work is to chemically and physically characterize the synthesized Hydroxyapatite (HAp) micro and nanoparticles and to explore the inhibitory effect of nano-HAps on the in vitro growth of human colon cancerous cells HCT116. HAp powder was synthesized using three different routes to achieve micro and nanosized powders, with different morphologies and crystallinity. The synthesized powders were characterized using X-ray diffraction, FTIR spectroscopy and scanning electron microscope. The results showed that the average crystallite size of HAp powder varies from 11nm to 177nm and respective crystallinity of powder found to be in the range of 0.12 and 0.92. The effect of these physico-chemical properties of HAp powders on human colon cancer HCT116 cells inhibition was determined in vitro. It was found that decreasing the HAp powder crystallite size between 11nm and 22nm significantly increases the HCT116 cell inhibition. Our results demonstrate that apart from HAp powder size their crystallinity and morphology also play an important role in cellular inhibition of human colon cancer cells.
本研究的目的是对合成的羟基磷灰石(HAp)微米和纳米颗粒进行化学和物理表征,并探索纳米HAp对人结肠癌细胞HCT116体外生长的抑制作用。采用三种不同的方法合成HAp粉末,以获得具有不同形态和结晶度的微米级和纳米级粉末。使用X射线衍射、傅里叶变换红外光谱和扫描电子显微镜对合成的粉末进行表征。结果表明,HAp粉末的平均晶粒尺寸在11nm至177nm之间变化,粉末的相应结晶度在0.12至0.92范围内。在体外测定了这些HAp粉末的物理化学性质对人结肠癌HCT116细胞抑制的影响。发现将HAp粉末晶粒尺寸减小到11nm至22nm之间可显著增加对HCT116细胞的抑制作用。我们的结果表明,除了HAp粉末尺寸外,其结晶度和形态在人结肠癌细胞的细胞抑制中也起着重要作用。